Publications by authors named "Kim Wedervang"

Claim this Profile
R
Remote Symptom Monitoring of Patients With Advanced Lung Cancer (The ProWide Study): A Randomized Controlled Trial.
Rasmus Blechingberg Friis, Helle Pappot, Niels Henrik Hjollund, Tine McCulloch, Marianne Ingerslev Holt, Kim Wedervang

JCO Oncol Pract· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan.
Morten Mau-Sørensen, Jonas Gerner-Rasmussen, Olfred Hansen, Bente Holm, Christa Haugaard Nyhus, Kim Wedervang

Acta Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-Year survival in Danish patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor monotherapy.
Birgitte Bjørnhart, Mette Thune Mouritzen, Charlotte Kristiansen, Tine Schytte, Kim Wedervang

Acta Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact of venous thromboembolism in non-small cell lung cancer patients receiving immunotherapy.
Birgitte Bjørnhart, Charlotte Kristiansen, Jon Asmussen, Karin Holmskov Hansen, Kim Wedervang

Thromb Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study.
Mette T Mouritzen, Karen F Junker, Andreas Carus, Morten Ladekarl, Peter Meldgaard, Kim Wedervang

Acta Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC-Real World Efficacy.
Mette T Mouritzen, Andreas Carus, Morten Ladekarl, Peter Meldgaard, Anders W M Nielsen, Kim Wedervang

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The NAME trial: a direct comparison of classical oral Navelbine versus Metronomic Navelbine in metastatic breast cancer.
Sven Tyge Langkjer, Julia Kenholm, Jeanette Dupont Jensen, Kim Wedervang, Annette Torbøl Brixen

Future Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis